|
A panel discussion of the challenges facing personalized medicine and a reception to launch the third edition of PMC's signature publication:
The Case for Personalized Medicine
WHAT
Panel Discussion Featuring:
-
Moderator: Jennie Hunter-Cevera, Ph.D., Executive Vice President, RTI International
-
Amy Abernethy, M.D., Director, Duke Cancer Care Research Program
-
Peter Collins, Ph.D., Vice President, Diagnostics, GlaxoSmithKline
-
David King, CEO, Laboratory Corporation of America
-
Eric Linsley, Managing Partner, Pappas Ventures
Cocktail Reception to Follow
WHEN
November 16, 2011
4:00 – 7:00 p.m.
WHERE
The North Carolina Biotechnology Center
15 T.W. Alexander Drive
Research Triangle Park, NC 27709
SPONSORED BY
|
ShareThis